AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Number Of Exists:
N/A
Technology:
COVID
Industry:
Vaccine/Drug
Founded Date:
N/A
Investor Type:
N/A
Employee Number:
N/A
Investment Stage:
N/A
Headquarters:
Denmark
Funding Status:
N/A